This was acknowledged through CONITEC's recent recommendation that tafenoquine following semi-quantitative G6PD screening be incorporated into the SUS, an essential milestone with Brazil becoming the first malaria-endemic country to introduce tafenoquine into its health system. Here, G6PD is linked to malaria.